Cargando…
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
INTRODUCTION: Duchenne muscular dystrophy (DMD) is a devastatingly severe genetic muscle disease characterized by childhood-onset muscle weakness, leading to loss of motor function and premature death due to respiratory and cardiac insufficiency. DISCUSSION: In the following three and half decades,...
Autores principales: | Ricci, Giulia, Bello, Luca, Torri, Francesca, Schirinzi, Erika, Pegoraro, Elena, Siciliano, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126754/ https://www.ncbi.nlm.nih.gov/pubmed/35608735 http://dx.doi.org/10.1007/s10072-022-06085-w |
Ejemplares similares
-
Genetic diagnosis as a tool for personalized
treatment of Duchenne muscular dystrophy
por: Bello, Luca, et al.
Publicado: (2016) -
The “Usual Suspects”: Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy
por: Bello, Luca, et al.
Publicado: (2019) -
Teaching an Old Molecule New Tricks: Drug Repositioning for Duchenne Muscular Dystrophy
por: Vitiello, Libero, et al.
Publicado: (2019) -
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015) -
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy?
por: Chiappalupi, Sara, et al.
Publicado: (2019)